September 18, 2025 a 08:39 am
HSIC: Analysts Ratings - Henry Schein, Inc.
Henry Schein, Inc. operates within the healthcare sector, delivering an extensive array of products and value-added services for dental and medical practitioners. Recent analyst ratings reflect a mixed sentiment, showing a tilt towards more conservative positions with a predominant Hold stance. This indicates potential caution in the market driven by economic uncertainties or specific company performance concerns.
Historical Stock Grades
The following table represents the latest analyst ratings for Henry Schein, Inc. for September 2025. There is a noticeable conservativeness in the recommendations, reflected in the high number of Hold ratings.
| Rating Type | Number | Score |
|---|---|---|
| Strong Buy | 3 | |
| Buy | 2 | |
| Hold | 9 | |
| Sell | 1 | |
| Strong Sell | 0 |
Sentiment Development
The sentiment towards Henry Schein's stock has shown signs of caution as evidenced by increasing Hold ratings. This trend suggests a steady retraction from aggressive Buy positions over recent months:
- The Hold ratings have shown a notable increase from 7 to 9 in the twelve-month view, indicating a shift towards caution.
- Strong Buy ratings remained somewhat stable but noticeably reduced from peaks observed in mid-2024.
- Analyst sentiment became more divided, with negligible changes in Sell and Strong Sell categories.
Percentage Trends
When analyzing the percentage distribution of analyst ratings over the past months, observable shifts indicate a market's growing hesitance:
- The percentage of Hold ratings has increased significantly, representing about 60% of total ratings in September 2025.
- A slight decrease is seen in Strong Buy recommendations, potentially flagging concerns about future growth or market conditions.
- The distribution reflects more conservative positions and potential anticipation of market volatilities.
Latest Analyst Recommendations
Recent analyst updates further underscore the general sentiment towards Henry Schein, Inc.:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-08-26 | Outperform | In Line | Evercore ISI Group |
| 2025-08-07 | Overweight | Overweight | JP Morgan |
| 2025-08-06 | In Line | In Line | Evercore ISI Group |
| 2025-08-06 | Neutral | Neutral | UBS |
| 2025-08-06 | Outperform | Outperform | Barrington Research |
Analyst Recommendations with Change of Opinion
Changes in analyst opinions provide deeper insights into the evolving perspective towards Henry Schein:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-08-26 | Outperform | In Line | Evercore ISI Group |
| 2025-07-25 | Hold | Buy | Stifel |
| 2025-07-14 | Neutral | Outperform | Baird |
| 2025-01-06 | Buy | Underperform | B of A Securities |
| 2024-07-22 | Outperform | Neutral | Baird |
Interpretation
The recent analyst activity indicates a cautious yet optimistic approach towards Henry Schein's stock. While the prevalence of Hold ratings suggests a need for prudence, the presence of Buy and Outperform recommendations also highlights some confidence in the company's strategic positioning. Analysts might be hesitant due to broader market conditions or company-specific factors, yet there is discernible underline trust in its long-term potential.
Conclusion
In summary, the analytical outlook for Henry Schein reflects both challenges and opportunities. Analysts show a clear inclination towards risk mitigation, evidenced by an increased number of Hold ratings, potentially due to external market pressures or internal business evaluations. Yet, the persistent presence of Buy recommendations aligns with possible strategic initiatives and earnings prospects that should not be overlooked.